HIV coinfection with hepatitis b laboratory findings: Difference between revisions
No edit summary |
m (Changes made per Mahshid's request) |
||
| Line 15: | Line 15: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
Latest revision as of 18:01, 18 September 2017
|
HIV coinfection with hepatitis b Microchapters |
|
Differentiating HIV coinfection with hepatitis b from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
HIV coinfection with hepatitis b laboratory findings On the Web |
|
American Roentgen Ray Society Images of HIV coinfection with hepatitis b laboratory findings |
|
HIV coinfection with hepatitis b laboratory findings in the news |
|
Blogs on HIV coinfection with hepatitis b laboratory findings |
|
Directions to Hospitals Treating HIV coinfection with hepatitis b |
|
Risk calculators and risk factors for HIV coinfection with hepatitis b laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Laboratory Findings
Accurate assessment of HBV infection in HIV coinfected individuals is necessary in order to base therapeutic decisions. [1]
WHO advocates HBsAg testing especially in areas of high HBV prevalence; but additional testing for HBV markers such as HBeAg and HBV DNA and to assess stage of liver disease (e.g. liver enzymes, liver biopsy) may not be widely available in many resource limited countries.
Hoffman and Thio provided management recommendations for use in areas with limited resources. They recommend that HBsAg and liver enzymes be tested before ART, with liver enzymes being repeated once or twice during the first 3 months after commencing ART. Detection of HBV DNA is helpful but may not be available. Chronic HBV carriers with HBeAg positivity may benefit from starting anti-HBV therapy early. [2]
References
- ↑ Thio CL (2009). "Hepatitis B and human immunodeficiency virus coinfection". Hepatology. 49 (5 Suppl): S138–45. doi:10.1002/hep.22883. PMID 19399813. Retrieved 2012-03-29. Unknown parameter
|month=ignored (help) - ↑ Hoffmann CJ, Thio CL (2007). "Clinical implications of HIV and hepatitis B coinfection in Asia and Africa". Lancet Infect Dis. 7 (6): 402–9. doi:10.1016/S1473-3099(07)70135-4. PMID 17521593. Retrieved 2012-03-29. Unknown parameter
|month=ignored (help)